Healthcare / Medical Care FacilitiesTokyo
$200.00
-7.00 (-3.35%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $122.4M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
57/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.1B
P/E
7.9x
↓EV/EBITDA
5.5x
↓ROE
15.2%
↑Gross Margin
34.3%
↓Debt/Equity
0.62
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-5.6%
FCF CAGR
—
FCF margin
5.0%
FCF / Net income
0.76x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.93B · net income $258.3M · FCF $197.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.93B | $3.93B | $4.23B | $4.50B | $4.67B |
| Net Income | $258.3M | $258.3M | $-36.7M | $54.0M | $2.1M |
| EBITDA | $360.5M | $360.5M | $146.8M | $228.1M | $190.6M |
| EPS | — | — | -3.59 | 5.43 | 0.22 |
| Gross Margin | 34.3% | 34.3% | 31.5% | 32.5% | 33.7% |
| Operating Margin | 3.6% | 3.6% | 0.1% | 1.1% | 0.1% |
| Net Margin | 6.6% | 6.6% | -0.9% | 1.2% | 0.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.62 | 0.62 | 0.89 | 1.06 | 1.46 |
| Current Ratio | 1.31 | 1.31 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $197.0M | $197.0M | $122.4M | $94.2M | $-288.9M |
| Returns | |||||
| ROE | 15.2% | 15.2% | -2.6% | 3.7% | 0.2% |
| Valuation | |||||
| P/E | 7.95 | 7.95 | — | 34.99 | 822.73 |
| EV/EBITDA | 5.48 | 5.48 | 10.96 | 10.01 | 12.81 |
| P/B | 1.21 | 1.21 | 0.96 | 1.30 | 1.35 |
| Growth & Yield | |||||
| Revenue Growth | -7.3% | -7.3% | -5.9% | -3.7% | — |
| EPS Growth | — | — | -166.1% | 2368.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+18.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-3.59 → n/d
Residual
+18.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.